CGRP Antagonist: A New Hope for Pediatric Abdominal Migraines

Research Summary

In a case report published in the journal Headache, researchers explored the use of a calcitonin gene-related peptide (CGRP) receptor antagonist to treat abdominal migraine in an 8-year-old child. Abdominal migraine, characterized by episodic abdominal pain, is less commonly discussed compared to typical migraine headaches. The study highlights the successful treatment of the child's symptoms with this novel approach. The findings suggest that CGRP receptor antagonists, typically used for classic migraines, could be beneficial for abdominal migraines as well. This case provides a promising outlook for alternative treatments in pediatric patients suffering from this uncommon form of migraine.

Study Details

📄 Title: Treatment of abdominal migraine in an 8-year-old child with calcitonin gene-related peptide receptor antagonist: A case report.

👥 Research Team: Tang Y et al.

📚 Published In: Headache

📅 Publication Date: 2025 Dec 10

⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.